Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Cerus Corp
(NQ:
CERS
)
6.180
USD
-0.170 (-2.68%)
Official Closing Price
Updated: 5:00 PM EDT, Apr 16, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Cerus Corp
< Previous
1
2
...
29
30
31
32
33
34
35
36
Next >
Advaxis Prevails in European Patent Court
January 14, 2009
From
Business Wire News Releases
Cerus Corporation Extends Manufacturing Agreement with Fenwal
December 15, 2008
From
Business Wire News Releases
Cerus Receives Expanded Label Claim for INTERCEPT Plasma System
December 04, 2008
From
Business Wire News Releases
Cerus Initiates Phase I Clinical Trial for INTERCEPT Red Blood Cell System
November 23, 2008
From
Business Wire News Releases
Cerus Corporation Announces Third Quarter Financial Results
October 30, 2008
Product sales of $3.1 million, loss of $8.8 million or $0.27 per share
From
Business Wire News Releases
Bacterial Risks Prompt German Safety Measures
October 22, 2008
Cerus Sees Opportunity in German Blood Ruling
From
Business Wire News Releases
Cerus Corporation to Release Third Quarter Financial Results
October 19, 2008
From
Business Wire News Releases
Cerus Presents Data on Intercept Blood System at AABB Annual Meeting
October 08, 2008
Results from 10 Studies Highlight the INTERCEPT Blood System's Ability to Improve the Safety of Donated Blood Components, Including Platelets, Plasma and Red Blood Cells
From
Business Wire News Releases
Cerus to Present at the JMP Securities Healthcare Conference
September 30, 2008
From
Business Wire News Releases
Cerus and German Red Cross to Collaborate on INTERCEPT Red Blood Cell System Development
September 14, 2008
From
Business Wire News Releases
Cerus to Present at the Baird Small Cap Health Care Conference
September 09, 2008
From
Business Wire News Releases
Zosano Pharma, Inc. Announces Appointment of Gail Schulze as Chair and CEO
September 08, 2008
From
PR Newswire
Cerus' INTERCEPT Blood System Receives CE Mark Label Expansion for Treatment of Previously Frozen Plasma
August 11, 2008
From
Business Wire News Releases
Cerus Corporation Announces Second Quarter Financial Results
July 31, 2008
From
Business Wire News Releases
Cerus Expands INTERCEPT Distribution Network
July 22, 2008
-- Chile, Indonesia and Poland Added --
From
Business Wire News Releases
Cerus Corporation to Release Second Quarter Financial Results
July 16, 2008
From
Business Wire News Releases
Cerus Secures $10 Million Revolving Credit Facility
June 19, 2008
From
Business Wire News Releases
Cerus Enters into Agreement to Supply INTERCEPT Platelet System to Largest Region of German Red Cross
June 11, 2008
From
Business Wire News Releases
Cerus Announces INTERCEPT Blood System Data Presented at International Society of Blood Transfusion Conference Support Broad Utility in Safeguarding the Blood Supply
June 09, 2008
Results from 32 Studies Highlight the INTERCEPT Blood System's Ability to Improve the Safety of Donated Blood by Inactivating Viruses, Bacteria, Protozoa and Leukocytes
From
Business Wire News Releases
Cerus to Present at Upcoming Investor Conferences in May
May 06, 2008
From
Business Wire News Releases
Cerus Corporation Announces First Quarter Financial Results
May 01, 2008
From
Business Wire News Releases
Cerus Receives Label Expansion on CE Marks for Use of INTERCEPT Blood System
April 21, 2008
From
Business Wire News Releases
Cerus Corporation to Release First Quarter Financial Results on Thursday, May 1, 2008
April 17, 2008
From
Business Wire News Releases
Cerus Appoints Carol M. Moore as Vice President, Regulatory Affairs and Quality
March 31, 2008
From
Business Wire News Releases
Cerus Announces Major Presence at Upcoming International Society of Blood Transfusion Conference
March 26, 2008
Results from 32 Studies Accepted for Presentation Highlight INTERCEPT Blood System's Potential to Improve the Safety of Donated Blood by Inactivating Viruses, Bacteria, Protozoa and Leukocytes
From
Business Wire News Releases
Cerus to Present at Cowen and Company 28th Annual Health Care Conference
March 10, 2008
From
Business Wire News Releases
Cerus Promotes Laurence M. Corash, M.D. to Senior Vice President and Chief Medical Officer
March 03, 2008
From
Business Wire News Releases
Cerus to Present at the Susquehanna Financial Group Second Annual SIGnificant Options in Healthcare Conference
February 25, 2008
From
Business Wire News Releases
Cerus Corporation Announces Fourth Quarter and Year-End Financial Results
February 21, 2008
From
Business Wire News Releases
CERUS to Present at Morgan Stanley's 11th Annual European MedTech Trip
February 18, 2008
From
Business Wire News Releases
< Previous
1
2
...
29
30
31
32
33
34
35
36
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.